stay tuned:
elixi news from the
world

New hope for the treatment of neurodegenerative diseases including Lewy bodies dementia and Parkinson’s disease

New hope for the treatment of neurodegenerative diseases including Lewy bodies dementia and Parkinson’s disease

A new research published in Neuropathology and Applied Neurobiology, has established that Toxic proteins within the brain that cause Parkinson’s disease and Lewy body dementia have the potential to help develop new targeted therapies.

Research into modified RNA messages could help treat diseases and develop new therapies

University of Nottingham experts – led by Dr Helen Miranda Knight – have discovered that the modification of ribonucleic acid (RNA) in human brain tissue is disrupted among neurodegenerative diseases. These conditions include Lewy bodies dementia and Parkinson’s disease.

You can read the full article here:

 

https://onlinelibrary.wiley.com/action/doSearch?AllField=modified+m6a&SeriesKey=13652990

 

Share this article

Condividi su twitter
Tweet
Condividi su facebook
Share
Condividi su pinterest
Pin it
Condividi su linkedin
Share

SEE Also

we are specialized in the procurement and distribution of pharmaceutical products, medical devices all over the world

Stay Tuned

Subscribe to our newsletter

    Contact us


      ELIXI International SA

      Vicolo Oldelli 1
      6830 Chiasso / Switzerland
      Email info@elixi-int.com
      Phone/Fax +41 91 6822040

      ELIXI International SA

      Copyright 2022 ELIXI International SA.   |   All Rights Reserved   |   Privacy Policy   |   Cookie Policy